Ventana's companion Dx to lung cancer drug wins Chinese approval

09/12/2013 | GenomeWeb Daily News (free registration)

Ventana Medical Systems received approval in China for its Ventana ALK Rabbit Monoclonal Primary Antibody test, which is used to pinpoint patients with nonsmall cell lung cancer who are positive for the anaplastic lymphoma kinase fusion gene. The assay has been approved for use as a companion diagnostic test to Pfizer's lung cancer drug Xalkori.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR